John Skidmore

4.3k total citations · 2 hit papers
32 papers, 2.1k citations indexed

About

John Skidmore is a scholar working on Organic Chemistry, Molecular Biology and Materials Chemistry. According to data from OpenAlex, John Skidmore has authored 32 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 15 papers in Molecular Biology and 5 papers in Materials Chemistry. Recurrent topics in John Skidmore's work include Synthetic Organic Chemistry Methods (10 papers), Chemical Synthesis and Reactions (7 papers) and Chemical Synthesis and Analysis (5 papers). John Skidmore is often cited by papers focused on Synthetic Organic Chemistry Methods (10 papers), Chemical Synthesis and Reactions (7 papers) and Chemical Synthesis and Analysis (5 papers). John Skidmore collaborates with scholars based in United Kingdom, United States and Germany. John Skidmore's co-authors include Duncan E. Scott, Chris Abell, Andrew R. Bayly, Michael J. Porter, Stanley M. Roberts, Karlheinz Drauz, Eleanna Stamatakou, Adrián Martín‐Segura, Motoki Fujimaki and Gregory J. Krause and has published in prestigious journals such as Neuron, Nature Neuroscience and Journal of Molecular Biology.

In The Last Decade

John Skidmore

30 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Small molecules, big targets: drug discovery faces the protein–protein interaction challenge

2016 802 citations Duncan E. Scott, Andrew R. Bayly et al. Nature Reviews Drug Discovery profile →
The different autophagy degradation pathways and neurodegeneration

2022 293 citations Angeleen Fleming, Mathieu Bourdenx et al. Neuron profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Skidmore United Kingdom	19	1.1k	813	206	190	160	32	2.1k
Pavel A. Petukhov United States	29	1.2k 1.0×	801 1.0×	121 0.6×	80 0.4×	250 1.6×	88	2.3k
John P. Mallamo United States	29	1.1k 1.0×	1.1k 1.4×	92 0.4×	129 0.7×	272 1.7×	64	2.3k
Pierfausto Seneci Italy	24	1.2k 1.0×	706 0.9×	91 0.4×	95 0.5×	147 0.9×	109	2.0k
Rongshi Li United States	23	1.0k 0.9×	789 1.0×	139 0.7×	149 0.8×	339 2.1×	44	2.2k
William Leister United States	27	1.3k 1.2×	1.4k 1.7×	80 0.4×	148 0.8×	203 1.3×	48	3.0k
Pavel Majer Czechia	31	1.6k 1.4×	565 0.7×	152 0.7×	182 1.0×	640 4.0×	117	3.3k
Murray J. B. Brown United Kingdom	28	2.2k 2.0×	879 1.1×	121 0.6×	100 0.5×	229 1.4×	41	3.2k
Donald S. Karanewsky United States	30	1.8k 1.6×	1.1k 1.3×	62 0.3×	149 0.8×	362 2.3×	77	3.0k
Lora Hamuro United States	23	2.0k 1.8×	510 0.6×	170 0.8×	68 0.4×	238 1.5×	47	2.7k
Christopher W. am Ende United States	27	1.3k 1.1×	1.7k 2.2×	123 0.6×	56 0.3×	171 1.1×	52	2.7k

Countries citing papers authored by John Skidmore

Since Specialization

Citations

This map shows the geographic impact of John Skidmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Skidmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Skidmore more than expected).

Fields of papers citing papers by John Skidmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Skidmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Skidmore. The network helps show where John Skidmore may publish in the future.

Co-authorship network of co-authors of John Skidmore

This figure shows the co-authorship network connecting the top 25 collaborators of John Skidmore. A scholar is included among the top collaborators of John Skidmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Skidmore. John Skidmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McGeachan, Robert I., S. Meftah, Jamie Rose, et al.. (2024). p-tau Ser356 is associated with Alzheimer’s disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003. Acta Neuropathologica. 147(1). 7–7. 15 indexed citations

Korte, Nils, Anna Barkaway, Jack A. Wells, et al.. (2024). Inhibiting Ca2+ channels in Alzheimer’s disease model mice relaxes pericytes, improves cerebral blood flow and reduces immune cell stalling and hypoxia. Nature Neuroscience. 27(11). 2086–2100. 18 indexed citations

Rooney, Timothy P. C., Henriëtte M. G. Willems, Christopher Green, et al.. (2023). The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K). RSC Medicinal Chemistry. 14(10). 2035–2047. 1 indexed citations

Willems, Henriëtte M. G., Simon Edwards, Christopher Green, et al.. (2023). Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor. RSC Medicinal Chemistry. 14(5). 934–946. 5 indexed citations

Ryan, Sean K., et al.. (2023). Therapeutic inhibition of ferroptosis in neurodegenerative disease. Trends in Pharmacological Sciences. 44(10). 674–688. 69 indexed citations

Fleming, Angeleen, Mathieu Bourdenx, Motoki Fujimaki, et al.. (2022). The different autophagy degradation pathways and neurodegeneration. Neuron. 110(6). 935–966. 293 indexed citations breakdown →

Scott, Duncan E., Timothy P. C. Rooney, Elliott D. Bayle, et al.. (2020). Systematic Investigation of the Permeability of Androgen Receptor PROTACs. ACS Medicinal Chemistry Letters. 11(8). 1539–1547. 53 indexed citations

Moschetti, Tommaso, Timothy Sharpe, Gerhard W. Fischer, et al.. (2016). Engineering Archeal Surrogate Systems for the Development of Protein–Protein Interaction Inhibitors against Human RAD51. Journal of Molecular Biology. 428(23). 4589–4607. 12 indexed citations

Scott, Duncan E., Andrew R. Bayly, Chris Abell, & John Skidmore. (2016). Small molecules, big targets: drug discovery faces the protein–protein interaction challenge. Nature Reviews Drug Discovery. 15(8). 533–550. 802 indexed citations breakdown →

10.

Ladbury, John E., et al.. (2014). The toolbox is open, but who should pay for the job?. Nature Reviews Drug Discovery. 13(7). 479–480. 1 indexed citations

11.

Kyle, Andrew F., et al.. (2011). Total synthesis of (−)-nakadomarin A. Chemical Communications. 47(36). 10037–10037. 63 indexed citations

12.

Dobbs, Adrian P., Sébastien Guesné, Robert Parker, et al.. (2010). A detailed investigation of the aza-Prins reaction. Organic & Biomolecular Chemistry. 8(5). 1064–1064. 49 indexed citations

13.

Lightfoot, Andrew P., James N.C. Kew, & John Skidmore. (2008). 3 α7 Nicotinic Acetylcholine Receptor Agonists and Positive Allosteric Modulators. Progress in medicinal chemistry. 46. 131–171. 31 indexed citations

14.

Dobbs, Adrian P., Robert Parker, & John Skidmore. (2007). Rapid access to CF3-containing heterocycles. Tetrahedron Letters. 49(5). 827–831. 22 indexed citations

15.

Bickley, J.F., et al.. (2003). Stereocontrolled conversion of some optically active (4S,5R)-dihydroisoxazoles into acyclic 3-acetamido-1,2-diols. Tetrahedron. 59(30). 5731–5736. 5 indexed citations

16.

Bentley, Paul A., et al.. (2001). The effect of the primary structure of the polypeptide catalyst on the enantioselectivity of the Juliá–Colonna asymmetric epoxidation of enones. Chemical Communications. 1616–1617. 27 indexed citations

17.

Drauz, Karlheinz, et al.. (2001). β-Peptides as catalysts: poly-β-leucine as acatalyst for the Juliá–Colonna asymmetric epoxidation ofenones. Chemical Communications. 2330–2330. 29 indexed citations

18.

Bickley, J.F., Adam T. Gillmore, Stanley M. Roberts, John Skidmore, & Alexander Steiner. (2001). Synthesis and reactions of some optically active epoxides formally derived from tertiary allylic alcohols. Journal of the Chemical Society Perkin Transactions 1. 1109–1115. 5 indexed citations

19.

Porter, Michael J., Stanley M. Roberts, & John Skidmore. (1999). Polyamino acids as catalysts in asymmetric synthesis. Bioorganic & Medicinal Chemistry. 7(10). 2145–2156. 67 indexed citations

20.

Allen, Joanne V., et al.. (1999). Polyamino acid-catalysed asymmetric epoxidation: Sodium percarbonate as a source of base and oxidant. Tetrahedron Letters. 40(29). 5417–5420. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact